Abstract
Pharmacoeconomics is a blend of economic methodology with clinical pharmacology and outcomes research with an objective to provide for more efficient and cost-effective treatments. By doing this, pharmacoeconomics is constantly faced with ethical decision-making problems. The problem lies with the attempt of using epistemologically objective methods on an intrinsically ontologically subjective subject matter. In this work we discuss the possibility of an epistemologically objective methodology of integration of measures of risk of non-cure into pharmaceutical pricing schemes.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
